Literature DB >> 15060531

Cutting the cost of drug development?

Michael D Rawlins1.   

Abstract

Mesh：

Year:  2004        PMID： 15060531     DOI： 10.1038/nrd1347

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  26 in total

1.  New approaches to rewarding pharmaceutical innovation.

Authors:  Paul Grootendorst; Aidan Hollis; David K Levine; Thomas Pogge; Aled M Edwards
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

2.  Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval.

Authors:  Mark Greener
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

3.  Neglected diseases.

Authors:  Michael D Rawlins
Journal:  BMJ       Date:  2005-02-19

4.  Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization.

Authors:  Johan C F van Luijn; Frank W J Gribnau; Hubert G M Leufkens
Journal:  Br J Clin Pharmacol       Date:  2006-12-07       Impact factor: 4.335

Review 5.  The risks of risk aversion in drug regulation.

Authors:  Hans-Georg Eichler; Brigitte Bloechl-Daum; Daniel Brasseur; Alasdair Breckenridge; Hubert Leufkens; June Raine; Tomas Salmonson; Christian K Schneider; Guido Rasi
Journal:  Nat Rev Drug Discov       Date:  2013-11-15       Impact factor: 84.694

Review 6.  Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.

Authors:  Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 7.  Alternative strategies for proof-of-principle studies of antibacterial agents.

Authors:  Axel Dalhoff; Andrej Weintraub; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 8.  Nitroso Diels-Alder (NDA) reaction as an efficient tool for the functionalization of diene-containing natural products.

Authors:  Serena Carosso; Marvin J Miller
Journal:  Org Biomol Chem       Date:  2014-10-14       Impact factor: 3.876

Review 9.  Naturally-Derived Biomaterials for Tissue Engineering Applications.

Authors:  Matthew Brovold; Joana I Almeida; Iris Pla-Palacín; Pilar Sainz-Arnal; Natalia Sánchez-Romero; Jesus J Rivas; Helen Almeida; Pablo Royo Dachary; Trinidad Serrano-Aulló; Shay Soker; Pedro M Baptista
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 10.  Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.

Authors:  Elliott Antman; Scott Weiss; Joseph Loscalzo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.